Is CareCloud (CCLD) Stock Outpacing Its Medical Peers This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. CareCloudCCLD--, Inc. (CCLD) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
CareCloud, Inc. is one of 892 individual stocks in the Medical sector. Collectively, these companies sit at #7 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. CareCloud, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for CCLD's full-year earnings has moved 2.5% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, CCLDCCLD-- has gained about 25% so far this year. At the same time, Medical stocks have lost an average of 4.6%. This means that CareCloud, Inc. is outperforming the sector as a whole this year.
One other Medical stock that has outperformed the sector so far this year is Bicara Therapeutics Inc. (BCAX). The stock is up 18.2% year-to-date.
For Bicara Therapeutics Inc., the consensus EPS estimate for the current year has increased 4.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, CareCloud, Inc. belongs to the Medical Info Systems industry, a group that includes 41 individual stocks and currently sits at #75 in the Zacks Industry Rank. Stocks in this group have lost about 25.4% so far this year, so CCLD is performing better this group in terms of year-to-date returns.
Bicara Therapeutics Inc., however, belongs to the Medical - Biomedical and Genetics industry. Currently, this 436-stock industry is ranked #150. The industry has moved +4.1% so far this year.
Investors interested in the Medical sector may want to keep a close eye on CareCloud, Inc. and Bicara Therapeutics Inc. as they attempt to continue their solid performance.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CareCloud, Inc. (CCLD): Free Stock Analysis Report
Bicara Therapeutics Inc. (BCAX): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Comentarios
Aún no hay comentarios